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interesting that the rate of expansion for your suprarenal aortic
aneurysms is lower than reported rates for infrarenal aneurysms.
Is there information about how many patients were on statins or
on the rate of hypertension? Were these patients more carefully
managed medically? Or perhaps the visceral segment is just more
stable?
Dr Benjamin J. Herdrich. I think based on this study it is
really unclear. We did not have demographic data on these
patients, so we don’t know what percentage were on statins or
what their blood pressure control was. We just had radiographic
data, such as the measurements of their aortas over time and
whether or not they had stent grafts and suprarenal ﬁxation. So
it is really hard to draw conclusions from these data to answer
your question.
As to why the suprarenal aorta growth rates were less than
reported growth rates in the infrarenal aorta, I would just be
speculating. I will say it is interesting that the growth rates in
our endovascular aortic repair (EVAR) patients were signiﬁcantly
less than the growth rates in our control patients. And while I
wouldn’t go out on a limb and say that this proves that EVAR
can promote remodeling of the suprarenal aorta, it is kind of an
interesting ﬁnding.
Dr Tara Mastracci (Cleveland, Ohio). I am interested to
know if you have any data on the rate of reintervention for the
infrarenal devices that were in these patients where you implanted
them with a concomitant aneurysm above. Speciﬁcally, did you
notice there was a rate of failure for the devices when you
implanted with an aneurysm so close?Dr Herdrich. This was primarily an anatomic study and not
designed to look at additional outcome measures. I did present
data showing that overall, for patients in both of our EVAR
groups, the mean infrarenal aortic aneurysm size and volume
decreased in both of those groups. Now, that wasn’t true for every
patient. Some of those patients did go on to have increasing aortic
size, and we really don’t have data on the outcomes of that. But
overall, I think that the procedures seemed to have been successful
given the fact that the infrarenal aneurysms shrunk.
Dr Mark Farber (Chapel Hill, NC). It appears these aren’t
necessarily your patients, these are M2S data sets that you are look-
ing atddo you have any data on what the size of the suprarenal
and superior mesenteric artery diameter is vs the infrarenal diam-
eter? In our experience, rarely do we ﬁnd patients with normal
suprarenal aortas and infrarenal aortic aneurysms that are
completely isolated, as they generally have a dilated segment.
Because we are getting ready to embark on fenestrated grafts
in the United States and we know from the Cleveland Clinic’s
experience that if you place grafts in already dilated or preaneurys-
mal segments they tend to fail at a much higher rate, I am surprised
that you haven’t looked at failure rates of the infrarenal devices
because I think it would be an interesting ﬁnding if you could
look into that and let us know what those diameters are if you
have that data.
Dr Herdrich. We just don’t have the data on the failure rates
because this was an anatomic study. As for the diameters, our
average diameters of our infrarenal aortic aneurysms for our control,
suprarenal, and infrarenal groups were 3.5 cm, 6 cm, and, I believe,
5.4 cm. Now, the diameter at the renals, or actually 1 mm below the
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our suprarenal aortic sizes were 34 to 36 mm. So there is some
infrarenal aortic neck in all of these patients. The average infrarenal
neck length was 18 to 22 mm, depending on the group. Now, in
some of the patients, the neck was only a couple millimeters;
however, in many patients, it was a sizable neck.
Dr Frederick Beavers (Washington, D.C.). I’d like to convert
this over to a little bit of just everyday practical medicine on two
points. Number one, the majority of us probably don’t use M2S
as an imaging modality. It costs money, and insurance doesn’t
cover it in a lot of locations. So we rely on our community radiol-
ogists to read the computed tomography (CT) scans for us, unless
we read them ourselves. Some reported literature says there is
interobserver error. And usually, if we rely on our community radi-
ologists, we won’t get the same radiologist reading this CT scan.
So how does that play into the data that you presented?
The second question is: There is a recent report out that in CT
scans in adolescents, there is an increased incidence of brain cancer
and leukemia. Once the lay public gets a hold of these data, I am
concerned that they may not want to follow these protocols that
we are putting forth. Do you have any data that magnetic reso-
nance (MR) technology is as sensitive as the CT scan results that
you’ve reported?Dr Herdrich. With regard to places that may not have access
to M2S, I think generally the measurements that we have pre-
sented here are fairly basic measurements that can be made on
a routine axial CT angiography. So I don’t know that you need
M2S to make these measurements, but the M2S database was
a good source to get a large number of patients that had these
concomitant aneurysms. I think out in the community, people
will still be able to use these data and make these measurements.
Dr Beavers. How about correlating the ability of MR tech-
nology to be equivalent to CT?
Dr Herdrich. Well, I think that whatever test you use to
measure the aortic size that as long as you get an accurate aortic
size that that is sufﬁcient. Now, with MR technology the question
is, do you get an accurate aortic size? And I think that there are
many factors that go into itdwhat type of stent graft is being
used, what is the material of the stent graft, what is the experience
with MR at your institutiondso you have to take all those things
into consideration.
We use ultrasound in some of these patients to monitor them,
and that is another alternative. In patients who are thin and you
can get good views of the aorta, they don’t necessarily need
a CT scan every 6 months or every year. You could consider using
ultrasound in those patients.
